Liposome Drug Delivery Market to hit USD 6,992.95 million, Globally, by 2027 at 8.8% CAGR: The Insight Partners

According to the new market research study of "Liposome Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy); and Geography," the market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The report highlights trends prevailing in the global liposome drug delivery market and the factors driving market along with those that act as hindrances.

Liposomes are rapidly gaining acceptance as nano-carriers for various pharmaceutical applications. Compositions of cholesterol and phospholipids are becoming increasingly useful in liposome drug delivery. As the nanoscience is optimizing liposome drug delivery, the pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol, as well as new techniques such as nanotechnology, to improve the stability and drug release profiles with the help of encapsulation and other methods. They are using liposomes for the generation of extracellular vesicles by targeted cells. Manufacturers in the liposome drug delivery market are ramping up their R&D activities for unlocking new lipid compositions and strategies that help optimize the drug transport and stability of liposomes. Similar experiments for innovative liposome fabrication are likely to offer growth opportunities for the market players to attain a significant position and grow in the liposome drug delivery market.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis - https://www.theinsightpartners.com/sample/TIPRE00010407/?utm_source=OpenPR&utm_medium=10408

North America held the largest share of the liposome drug delivery market. The burgeoning penetration of nanotechnology in drug delivery systems translated into commercially viable products is likely to be responsible for the dominance of the market. Furthermore, the presence of key market leaders in the region investing huge amounts in R&D of new drug delivery channels to improve the efficacy of drugs are expected to come up with novel liposomal solutions in the near future securing potential growth in the market. On the other hand, Asia Pacific is currently a niche market and has high potential for growth, which is attributed to the increasing number of patients with chronic diseases and growing R&D spending by pharmaceutical giants in the region, thereby opening opportunities for developing robust pipeline for liposomal drugs. In addition, the rising disposable incomes among Asian population leading to increasing awareness toward healthy lifestyle is likely to propel the market growth.

Leading companies operating in the liposome drug delivery market are Takeda Pharmaceutical Company Limited, Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc., Gilead Sciences, Inc., Astellas Pharma, Inc., Johnson & Johnson Services, Inc., and Acrotech Biopharma, Inc.

Have a 15-minute-long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well - https://www.theinsightpartners.com/speak-to-analyst/TIPRE00010407?utm_source=OpenPR&utm_medium=10408

The report analyzes Liposome Drug Delivery Market on the basis of following segments:

By Product
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others

By Technology
Stealth Liposome Technology
Non-PEGylated Liposome Technology
DepoFoam Liposome Technology
Lysolipid Thermally Sensitive Liposome (LTSL) Technology

By Application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy

By Geography

North America
US
Canada
Mexico

Europe
France
Germany
UK
Spain
Italy

Asia Pacific (APAC)
China
India
Japan
Australia
South Korea

Middle East and Africa
Saudi Arabia
UAE
South Africa

South and Central America
Brazil
Argentina

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods -
https://www.theinsightpartners.com/buy/TIPRE00010407/?utm_source=OpenPR&utm_medium=10408

Contact Us
If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Healthcare, Media, and Telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, products, applications, end users etc., which helps our clients to gain a deeper analytical understanding of various research topics.

This release was published on openPR.